Articles dans des revues avec comité de lecture (173)
  1. 71. Guillaume, M.-P., Karmali, R., Bergmann, P., & Cogan, E. (1997). Unusual prolonged hypercalcemia due to Foscarnet in a patient with AIDS. Clinical Infectious Diseases, 25, 932-933.
  2. 72. Delbaere, A., Bergmann, P., Gervy Decoster, C., De Maertelaer, V., Camus, M., & Englert, Y. (1997). Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome. Human Reproduction, 12(2), 236-240. doi:10.1093/humrep/12.2.236
  3. 73. Peretz, A., Moris, M., Willems, D., & Bergmann, P. (1996). Is bone alkaline phosphatase an adequate marker of bone metabolism during acute corticosteroid treatment? Clinical Chemistry (Washington, DC), 42, 102-103.
  4. 74. Delbaere, A., Bergmann, P., Gervy Decoster, C., Deschodt Lanckman, M., De Maertelaer, V., & Englert, Y. (1996). Periovulatory elevation of angiotensin II in the peritoneal fluid during the human menstrual cycle. The Journal of clinical endocrinology and metabolism, 81(8), 2810-2815. doi:10.1210/jc.81.8.2810
  5. 75. Peretz, A., Body, J.-J., Dumon, J. C., Rozenberg, S., Hotimsky, A., Praet, J. P., Moris, M., Ham, H., & Bergmann, P. (1996). Cyclical pamidronate infusions in postmenopausal osteoporosis. Maturitas, 25(1), 69-75.
  6. 76. Delbaere, A., Englert, Y., Bergmann, P., De Prez, E., Giot, J. M., & Deschodt Lanckman, M. (1996). Bioactive angiotensin (1-8) is the main component of angiotensin II immunoreactivity in human follicular fluid. Peptides, 17(7), 1135-1138. doi:10.1016/S0196-9781(96)00184-2
  7. 77. Moris, M., Peretz, A., Tjeka, R., Negaban, N., Wouters, M., & Bergmann, P. (1995). Quantitative ultrasound bone measurements: normal values and comparison with bone mineral density by dual X-ray absorptiometry. Calcified tissue international, 57(1), 6-10. doi:10.1007/BF00298988
  8. 78. Chanoine, J.-P., Rebuffat, E., Kahn, A., Bergmann, P., & Van Vliet, G. (1995). Glucose, growth hormone, cortisol, and insulin responses to glucagon injection in normal infants, aged 0.5-12 months. The Journal of clinical endocrinology and metabolism, 80(10), 3032-3035.
  9. 79. Bergmann, P., & Schoutens, A. (1995). Prostaglandins and bone. Bone, 16, 485-488.
  10. 80. Heinrichs, C., Toppet, M., Perlmutter, N., Keutgen, H., Loveridge, N., Mallet, E., Herens, C., & Bergmann, P. (1995). Infant hypothyroidism as the first manifestation of pseudohypoparathyroidism type Ia. Clinical Pediatric Endocrinology, 4, 47-53.
  11. 81. Wilmet, E., Ismail, A. A., Heilporn, A., Welraedts, D., & Bergmann, P. (1995). Longitudinal study of the bone mineral content and of soft tissue composition after spinal cord section. Paraplegia, 33, 674-677.
  12. 82. Delbaere, A., Bergmann, P., Gervy Decoster, C., Staroukine, M., & Englert, Y. (1995). Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management. ACOG Current Journal Review, 8(2), 28.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Suivant >>